Weekly Stock Market Analysis and Top Gainers This Week
Get the latest weekly stock market analysis with insights on trends, movers, and top gainers this week and see which stocks are making waves!
Mar 29 2025
Traders who love volatility and momentum had plenty to cheer about this week as several stocks saw explosive moves fueled by game-changing announcements, sector tailwinds, and earnings beats. The rally was led by DatChat ($DATS), which skyrocketed 59.72% after launching a new social media platform. With digital privacy and alternative social networks gaining traction, investors appear to be speculating on the company's ability to carve out a niche. However, with trading volume at 1.36M, well below its 5.74M average, sustainability remains a key question.
Traders who love volatility and momentum had plenty to cheer about this week as several stocks saw explosive moves fueled by game-changing announcements, sector tailwinds, and earnings beats. The rally was led by DatChat ($DATS), which skyrocketed 59.72% after launching a new social media platform. With digital privacy and alternative social networks gaining traction, investors appear to be speculating on the company's ability to carve out a niche. However, with trading volume at 1.36M, well below its 5.74M average, sustainability remains a key question.
Meanwhile, Soleno Therapeutics ($SLNO) surged 43.58% after securing FDA approval for its first commercial drug, Vykat XR, aimed at treating hyperphagia in patients with Prader-Willi Syndrome. The stock exploded as the market digested the significance of this approval, which opens the door to a lucrative rare disease market. Adding fuel to the fire, options activity suggested some big money was making calculated bets, further intensifying momentum. While a high 5.09M volume (well above the 1.20M average) suggests strong conviction, profit-taking could soon follow.
Another standout was Markforged ($MKFG), jumping 39.33% after reporting Q4 and full-year results. While GAAP EPS of -$4.22 missed estimates by $0.51, revenue of $85.09M narrowly beat expectations, giving traders something to work with. With industrial 3D printing gaining traction and Markforged positioning itself as a leader, the stock's rally could signal renewed interest in the sector. However, with a relatively modest 282.69K volume, this move may need more follow-through to confirm a lasting breakout.
Nkarta ($NKTX) also saw an impressive 29.03% gain after its Q4 results revealed a smaller-than-expected EPS loss. The company's restructuring efforts, including a 34% workforce reduction, were well-received as a means to extend its cash runway. With a cash balance of $380.5M, Nkarta is playing the long game, making it an intriguing but speculative biotech play.
QuantaSing Group ($QSG) surged 27.14% after announcing a strategic expansion into the pop toys sector through an investment in Letsvan. This move diversifies the company’s revenue streams and positions it in a rapidly growing market segment. However, trading volume of 619.27K, significantly above its 106.31K average, suggests this was a heavily traded event that may need further catalysts for sustained momentum.
Lastly, Concentrix ($CNXC) gained 26.56% following its Q1 earnings beat. The company posted $2.79 EPS, exceeding estimates by $0.20, while revenue of $2.37B remained in line. With shares spiking on this news, the stock joined the ranks of other earnings-driven movers this week. A volume spike to 3.24M, well above the 910.33K average, confirms significant institutional interest.
With momentum names in full swing, the coming week will be crucial in determining which of these gains can be sustained. Whether driven by fundamental catalysts or speculative interest, these stocks have captured traders’ attention, setting the stage for another high-energy week in the markets.
Unlock Exclusive Stock Insights!
Join StocksRunner.com for daily market updates, expert analyses, and actionable insights.
Signup now for FREE and stay ahead of the market curve!
Why Join?
Find out what 10,000+ subscribers already know.
Real-time insights for informed decisions.
Limited slots available, SignUp Now!
Please note that the article should not be considered as investment advice or marketing, and it does not take into account the personal data and requirements of any individual. It is not a substitute for the reader's own judgment, and it should not be considered as advice or recommendation for buying or selling any securities or financial products.